NG2 precursor cells in neoplasia: Functional, histogenesis and therapeutic implications for malignant brain tumours

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neurocytology

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1025795715377PMID 14501220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab′)2-a preliminary report

  2005cited by this paper
• Immunohistochemical investigation of collagen subtypes in human glioblastomas

  2004cited by this paper
• The distribution of laminin in human brain tumors: An immunohistochemical study

  2004cited by this paper
• NG2 proteoglycan promotes angiogenesis‐dependent tumor growth in the central nervous system by sequestering angiostatin

  2002cited by this paper
• NG2 proteoglycan expression by pericytes in pathological microvasculature.

  2002cited by this paper
• NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors

  2002cited by this paper
• The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours

  2002cited by this paper
• Long term response in a patient with neoplastic meningitis secondary to melanoma treated with 131I‐radiolabeled antichondroitin proteoglycan sulfate Mel‐14 F(ab′)2

  2001cited by this paper
• Proliferation of NG2-Positive Cells and Altered Oligodendrocyte Numbers in the Contused Rat Spinal Cord

  2001cited by this paper
• Preeclamptic serum enhances endothelin-converting enzyme expression in cultured endothelial cells.

  2001cited by this paper
• The response of adult oligodendrocyte progenitors to demyelination in EAE.

  2001cited by this paper
• NG2 immunoreactivity on human brain endothelial cells

  2001cited by this paper
• Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion

  2001cited by this paper
• Late Oligodendrocyte Progenitors Coincide with the Developmental Window of Vulnerability for Human Perinatal White Matter Injury

  2001cited by this paper
• Hyaluronate Receptors Mediating Glioma Cell Migration and Proliferation

  2001cited by this paper
• Characterization of initiated cells in N-methylnitrosourea-induced carcinogenesis of the CNS in the adult rat.

  2001cited by this paper
• NG2 cells in the brain: a novel glial cell population.

  2001cited by this paper
• The oligodendrocyte precursor cell in health and disease.

  2001cited by this paper
• Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain

  2001cited by this paper
• NG2/HMPG modulation of human articular chondrocyte adhesion to type VI collagen is lost in osteoarthritis

  2001cited by this paper
• Migration and invasion in brain neoplasms

  2001cited by this paper
• TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

  2001cited by this paper
• NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis

  2001cited by this paper
• The glioma‐associated gangliosides 3′‐isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains

  2001cited by this paper
• Guidance of glial precursor cell migration by secreted cues in the developing optic nerve.

  2001cited by this paper
• Glioma Cell Motility is Associated with Reduced Transcription of Proapoptotic and Proliferation Genes: A cDNA Microarray Analysis

  2001cited by this paper
• Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization.

  2001cited by this paper
• Glial differentiation and lineages

  2000cited by this paper
• Integrin cell adhesion receptors and the concept of agonism.

  2000cited by this paper
• NG2‐expressing cells in the central nervous system: Are they oligodendroglial progenitors?

  2000cited by this paper
• Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen)*

  2000cited by this paper
• Comparing Astrocytic Cell Lines that Are Inhibitory or Permissive for Axon Growth: the Major Axon-Inhibitory Proteoglycan Is NG2

  1999cited by this paper
• PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse.

  1999cited by this paper
• Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration.

  1999cited by this paper
• Identification of a neural stem cell in the adult mammalian central nervous system.

  1999cited by this paper
• High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan*

  1999cited by this paper
• Cycling cells in the adult rat neocortex preferentially generate oligodendroglia

  1999cited by this paper
• Expression of a homologue of rat NG2 on human microglia

  1999cited by this paper
• NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases

  1999cited by this paper
• The glial scar and central nervous system repair.

  1999cited by this paper
• Integrin-binding peptides derived from phage display libraries.

  1999cited by this paper
• Regeneration of a germinal layer in the adult mammalian brain.

  1999cited by this paper
• NG2 proteoglycan-binding peptides target tumor neovasculature.

  1999cited by this paper
• Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter

  1999cited by this paper
• "...those left behind." Biology and oncology of invasive glioma cells.

  1999cited by this paper
• Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors.

  1999cited by this paper
• The extracellular matrix of gliomas: modulation of cell function.

  1999cited by this paper
• Identification of A2B5-positive putative oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white matter.

  1999cited by this paper
• Tumor targeting with a selective gelatinase inhibitor

  1999cited by this paper
• Neurogenesis in the neocortex of adult primates.

  1999cited by this paper
• Glial Tumors in the MNU Rat Model: Induction of Pure and Mixed Gliomas that Do Not Require Typical Missense Mutations of p53

  1998cited by this paper
• Microglia-specific localisation of a novel calcium binding protein, Iba1.

  1998cited by this paper
• Central nervous system stem cells in the embryo and adult

  1998cited by this paper
• Stem cells of the central nervous system.

  1998cited by this paper
• Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells transformed with c-myc and H-ras form high-grade glioma after stereotactic injection into the rat brain.

  1998cited by this paper
• Neurogenesis in the adult human hippocampus

  1998cited by this paper
• Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development.

  1998cited by this paper
• Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress.

  1998cited by this paper
• Not all myofibroblasts are alike: revisiting the role of PDGF‐A and PDGF‐B using PDGF‐targeted mice

  1998cited by this paper
• Distribution of perlecan in mouse hippocampus following intracerebroventricular kainate injections.

  1998cited by this paper
• Reactions of oligodendrocyte precursor cells to alpha herpesvirus infection of the central nervous system

  1998cited by this paper
• The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.

  1998cited by this paper
• Role of the CNS microvascular pericyte in the blood‐brain barrier

  1998cited by this paper
• Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells

  1998cited by this paper
• A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen.

  1997cited by this paper
• Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors

  1997cited by this paper
• A cancer therapy resistant to resistance

  1997cited by this paper
• Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia.

  1997cited by this paper
• In situ expression of fibroblast growth factor receptors by oligodendrocyte progenitors and oligodendrocytes in adult mouse central nervous system

  1997cited by this paper
• Normal and reactive NG2+ glial cells are distinct from resting and activated microglia

  1997cited by this paper
• Type VI Collagen Anchors Endothelial Basement Membranes by Interacting with Type IV Collagen*

  1997cited by this paper
• The Membrane-spanning Proteoglycan NG2 Binds to Collagens V and VI through the Central Nonglobular Domain of Its Core Protein*

  1997cited by this paper
• Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

  1997cited by this paper
• Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo

  1997cited by this paper
• Control of angiogenesis by the pericyte: molecular mechanisms and significance.

  1997cited by this paper
• Isolation and characterization of human malignant glioma cells from histologically normal brain.

  1997cited by this paper
• Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

  1997cited by this paper
• The adult rat hippocampus contains primordial neural stem cells.

  1997cited by this paper
• Co‐localization of NG2 proteoglycan and PDGF α‐receptor on O2A progenitor cells in the developing rat brain

  1996cited by this paper
• Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.

  1996cited by this paper
• Novel peptide ligands for integrin alpha 6 beta 1 selected from a phage display library.

  1996cited by this paper
• Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models.

  1996cited by this paper
• High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

  1996cited by this paper
• Glycolipids and myelin proteins in human oligodendrogliomas

  1996cited by this paper
• Molecular Cloning of F4/80, a Murine Macrophage-restricted Cell Surface Glycoprotein with Homology to the G-protein-linked Transmembrane 7 Hormone Receptor Family (*)

  1996cited by this paper
• Dichotomy of astrocytoma migration and proliferation

  1996cited by this paper
• Interaction of the NG2 proteoglycan with the actin cytoskeleton

  1996cited by this paper
• The use of a combinatorial library method to isolate human tumor cell adhesion peptides

  1996cited by this paper
• Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alpha-receptors.

  1996cited by this paper
• The role of the extracellular matrix in neoplastic glial invasion of the nervous system.

  1996cited by this paper
• Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro.

  1996cited by this paper
• Binding of the NG2 Proteoglycan to Type VI Collagen and Other Extracellular Matrix Molecules*

  1996cited by this paper
• Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.

  1996cited by this paper
• Excerpts from “Tumors Arising from the Blood-vessels of the Brain: Angiomatous Malformations and Hemangioblastomas”

  1996cited by this paper
• The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.

  1996cited by this paper
• Vascular and perivascular GD3 expression in human glioma.

  1996cited by this paper
• Interaction between NG2 proteoglycan and PDGF α‐receptor on O2A progenitor cells is required for optimal response to PDGF

  1996cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins

  1995cited by this paper
• The microglial cell. A historical review.

  1995cited by this paper

• MiR 329/449 Suppresses Cell Proliferation, Migration and Synergistically Sensitizes GBM to TMZ by Inhibiting Src/FAK, NF-kB, and Cyclin D1 Activity

  2025cites this paper
• Possible Involvement of CSPG4 in Promoting Endothelial Cell Migration and Contributing to Angiogenesis during Skeletal Muscle Regeneration and Development in the Rat

  2025cites this paper
• NG2/CSPG4 attenuates motility in mandibular fibrochondrocytes under serum starvation conditions

  2023cites this paper
• Chemistry and Function of Glycosaminoglycans in the Nervous System.

  2023cites this paper
• Degenerative and cognitive diseases.

  2023cites this paper
• Molecular Pathogenesis of Glioblastoma in Adults and Future Perspectives: A Systematic Review

  2022cites this paper
• Exogenous FGF-1 Differently Regulates Oligodendrocyte Replenishment in an SCI Repair Model and Cultured Cells

  2022cites this paper
• Chondroitin Sulphate Proteoglycans in the Tumour Microenvironment.

  2020cites this paper
• Tumor Microenvironment: Extracellular Matrix Components – Part B

  2020influential citation
• Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas

  2020cites this paper
• University of Birmingham A non-hierarchical organisation of tumorigenic NG2 cells in glioblastoma promoted by EGFR in

  2019cites this paper
• The post-surgical era of GBM: How molecular biology has impacted on our clinical management. A review.

  2018cites this paper
• The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas

  2018cites this paper
• A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR

  2018cites this paper
• Gene network underlying the glial regenerative response to central nervous system injury

  2018cites this paper
• "NG2 Proteoglycan in the Diagnosis, Prognosis and Therapy of Gliomas"

  2017influential citation
• 13 Genetics and Biology of Glioblastoma Multiforme

  2017cites this paper
• Brain repair from intrinsic cell sources: Turning reactive glia into neurons.

  2017cites this paper
• Evaluation of the therapeutic potential of red clover extract and red grape seed extract on human adult malignant brain tumours in vitro

  2017cites this paper
• Deacetylation of GD3A as a potential therapeutic strategy for paediatric medulloblastoma

  2016cites this paper
• The response of NG2-glia after traumatic brain injury

  2016cites this paper
• Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins

  2015cites this paper
• Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro.

  2015cites this paper
• Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse

  2015cites this paper
• Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.

  2015cites this paper
• of two glioblastoma-associated stromal cell subtypes with dierent carcinogenic properties in histologically normal surgical margins.

  2015cites this paper
• Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors

  2015cites this paper
• Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors.

  2014cites this paper
• Angiogenesis in Gliomas

  2014cites this paper
• NG2/CSPG4 Proteoglycan as a Novel Prognostic Indicator and Therapeutic Target in Malignant Cancer

  2014cites this paper
• Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan

  2013cites this paper
• Diversified Expression of NG2/CSPG4 Isoforms in Glioblastoma and Human Foetal Brain Identifies Pericyte Subsets

  2013cites this paper
• Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens

  2013cites this paper
• A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular Profiles.

  2012cites this paper
• Molecular mechanisms of amoeboid invasion of cancer cells

  2012cites this paper
• Progenitors in the intact brain parenchyma and their reaction towards acute injury

  2012cites this paper
• Cancer stem cells and markers: New model of tumorigenesis with therapeutic implications

  2011cites this paper
• Roles of NG2 glial cells in diseases of the central nervous system

  2011cites this paper
• Three-Dimensional In Vitro Models in Glioma Research - Focus on Spheroids

  2011cites this paper
• Genetics and Biology of Glioblastoma Multiforme

  2011cites this paper
• Differenzierung und angiogenes Potenzial humaner mesenchymaler Stammzellen in Abhängigkeit von tumorkonditioniertem Medium des Glioblastoma multiforme

  2011cites this paper
• Roles of NG2 glial cells in diseases of the central nervous system

  2011cites this paper
• Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.

  2011cites this paper
• Stem cell origin of brain tumors.

  2010cites this paper
• PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2

  2010cites this paper
• Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.

  2010cites this paper
• The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma.

  2010cites this paper
• Modeling Gliomas Using PDGF-Expressing Retroviruses

  2009cites this paper
• Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.

  2008cites this paper
• Identifying candidate genes involved in brain tumor formation

  2008cites this paper
• Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach.

  2008cites this paper
• A role for the NG2 proteoglycan in glioma progression

  2008cites this paper
• Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord.

  2008cites this paper
• Expression Sites of Colligin 2 in Glioma Blood Vessels

  2008cites this paper
• Cytokines and Extracellular Matrix Remodeling in the Central Nervous System * * This Chapter is dedicated to the memory of Dr. Christopher Phelps

  2008cites this paper
• Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements

  2008cites this paper
• Identifying candidate genes involved in brain tumor formation

  2008cites this paper
• Thrombospondin type-1 repeats and their potential role in inhibiting glioblastoma angiogenesis

  2008cites this paper
• The History of Neuroimmune Biology

  2008influential citation
• CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma

  2007cites this paper
• Investigation of tumour characteristics and treatment strategies in animal models using multiparametric MRI and novel contrast agents

  2007cites this paper
• Markers in normal and cancer stem cells

  2007cites this paper
• Genetic analysis to complement histopathological diagnosis of brain tumors.

  2007cites this paper
• NG2 expression regulates vascular morphology and function in human brain tumours

  2006cites this paper
• Olig gene function in CNS development and disease

  2006cites this paper
• Functional and morphological effects of NG2 proteoglycan deletion on hippocampal neurogenesis.

  2006cites this paper
• Screening for Candidate Brain Tumor Genes : Identifying Genes that Cooperate with Platelet-Derived Growth Factor in Glioma Development and Progression

  2006cites this paper
• Glial Progenitors in Adult White Matter Are Driven to Form Malignant Gliomas by Platelet-Derived Growth Factor-Expressing Retroviruses

  2006cites this paper
• Proteoglycan control of cell movement during wound healing and cancer spreading.

  2005cites this paper
• Cancer stem cells in the mammalian central nervous system

  2005cites this paper
• [Criteria of diagnosis and grading of oligodendrogliomas or oligo-astrocytomas according to the WHO and Sainte-Anne classifications].

  2005cites this paper
• The Role of the Extracellular Matrix in Angiogenesis in Malignant Glioma Tumors

  2005cites this paper
• Morphological, immunocytochemical and flow cytometric in vitro characterisation of a surface-adherent medulloblastoma.

  2005cites this paper
• Oligodendrogliomes et oligo-astrocytomes critères diagnostiques et grading de malignité selon l’oms et l’hôpital sainte-anne

  2005cites this paper
• NG2‐expressing cells in the nervous system: role of the proteoglycan in migration and glial–neuron interaction

  2005cites this paper
• In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.

  2005cites this paper
• Neural stem cells and the origin of gliomas.

  2005cites this paper
• The role of the NG2 proteoglycan in migration and characterization of the interaction with the intracellular binding partner, Syntenin.

  2005cites this paper
• Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance.

  2004cites this paper
• Glioma invasion: mechanism, modulation and future possibilities

  2003cites this paper